Cornelia Marty
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Nanoparticle-Based Drug Delivery 4
-
- Monoclonal and Polyclonal Antibodies Research 2
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Reto Albert Schwendener (8 shared papers)Kurt Ballmer‐Hofer (7 shared papers)B Odermatt (2 shared papers)Steffen M. Zeisberger (1 shared paper)Carlos Garcı́a-Echeverrı́a (1 shared paper)Herbert N. Schott (3 shared papers)Rom E. Eliaz (1 shared paper)Francis C. Szoka (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)Cancer Letters (1 paper)Bioconjugate Chemistry (1 paper)Protein Expression and Purification (1 paper)Cancer Research (1 paper)
- Partner nations
- SwitzerlandGermanyIsrael
In The Last Decade
Cornelia Marty
10 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 74
- Biomaterials 309
- Immunology 342
- Molecular Biology 486
- Oncology 129
- Pharmaceutical Science 39
Countries citing papers authored by Cornelia Marty
This map shows the geographic impact of Cornelia Marty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Marty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Marty more than expected).
Fields of papers citing papers by Cornelia Marty
This network shows the impact of papers produced by Cornelia Marty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Marty. The network helps show where Cornelia Marty may publish in the future.
Co-authors
The 16 scholars most cited alongside Cornelia Marty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 540 | |
| 2 | 2003 | 362 | |
| 3 | 2004 | 133 | |
| 4 | 2004 | 101 | |
| 5 | 2005 | 76 | |
| 6 | 2002 | 65 | |
| 7 | 2005 | 36 | |
| 8 | 2001 | 32 | |
| 9 | 2004 | 25 | |
| 10 | 2007 | 9 |
About Cornelia Marty
Cornelia Marty is a scholar working on Biomaterials, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Oncology, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lymphatic System and Diseases (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Immune cells in cancer (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Biomaterials (309 citations), Immunology (342 citations), Molecular Biology (486 citations), Oncology (129 citations) and Pharmaceutical Science (39 citations). Cornelia Marty has collaborated with scholars based in Switzerland, Germany and Israel. Frequent co-authors include Reto Albert Schwendener, Kurt Ballmer‐Hofer, B Odermatt, Steffen M. Zeisberger, Carlos Garcı́a-Echeverrı́a, Herbert N. Schott, Rom E. Eliaz, Francis C. Szoka, Shlomo Nir and Roman Klemenz. Their work appears in journals such as British Journal of Cancer, Cancer Letters, Bioconjugate Chemistry, Protein Expression and Purification and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.